Simulation Modeling

We project long-term, population outcomes to support healthcare and policy leaders in setting treatment and harm reduction priorities to care for people who use substances.

Substance use disorder is not a solo epidemic–it is one part of a syndemic that also encompasses greater risks for HCV, HIV, and injection-related bacterial infections. The broad spectrum of clinical and economic consequences of this syndemic compels us to use simulation modeling to measure the long-term economic value of interventions in innovative ways.